More on SNY
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $45.00 |
|
|||
| Open | $44.08 | ||||
| 52 Wk High | $44.76 | ||||
| 52 Wk Low | $36.81 | ||||
| Day High | $44.63 | ||||
| Day Low | $44.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 6,449,544 | ||||
- Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
- Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
- Form 6-K Sanofi For: Mar 04
- Form 6-K Sanofi For: Mar 03
- Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
- DNDi and Sanofi drug receives CHMP positive opinion for sleeping sickness
- Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
- Form 6-K Sanofi For: Feb 23
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR80 at Citi
- Form SCHEDULE 13G/A Sanofi Filed by: Amundi
Entities mentioned with SNY
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- JPMorgan | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
